FOOD
AND DRUG ADMINISTRATION
Center
for Drug Evaluation and Research
PULMONARY-ALLERGY DRUGS ADVISORY
COMMITTEE MEETING
.FDA Presentation
The
Montreal Protocol and the status Robert
Meyer, M.D.
of Essential
Use process (21 CFR 2.125) Director,
Office of Drug Evaluation II
Open Public Speakers
Alan Krueger, MS
Kos Life Sciences, Inc.